The 2026 tau imaging news means many memory workups will start with a blood test, then add tau PET only when needed. Tau PET is a brain scan that maps tau tangles, twisted proteins tied to Alzheimer's disease. Mild cognitive impairment means memory lapses beyond normal aging that do not block daily life. For this group, the new path helps doctors decide if amyloid or tau testing should follow.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What Changed in August 2026
- Do You Need PET Right Away
- What Does a Tau PET Result Mean
- Does Tau Imaging Help Predict Decline
- What to Ask at Your Visit
What Changed in August 2026
On Aug. 14, 2026, FDA approved Tauklarify (florquinitau F 18) for tau PET in adults with cognitive impairment. The scan is for people evaluated for Alzheimer's disease to detect tau tangle pathology. According to the FDA approval notice from Lantheus, the tracer was formerly called MK-6240.
On Aug. 24, 2026, FDA cleared Roche's Elecsys Phospho-Tau 217P plasma test for adults 55 and older with signs of decline. The Alzheimer's Association describes it as a single-biomarker aid to rule amyloid pathology in or out. Together, the two clearances add a blood-first option plus a tau-imaging option.
Do You Need PET Right Away
For mild cognitive impairment, doctors can use a validated pTau217 blood result to decide on next steps. A clear result may avoid PET or spinal-fluid testing, while an unclear result can point to amyloid PET, tau PET, or spinal-fluid testing. According to the test rollout update from Quest Diagnostics via BioBuzz, PET is no longer the automatic first step.
This sequence matters because tau PET requires a specialty center, tracer injection, and scan time. Blood testing fits a clinic visit and returns a number your doctor can explain. Ask whether your blood result was validated for this triage use.
What Does a Tau PET Result Mean
In two pivotal trials summarized by NeurologyLive, five blinded readers reached positive agreement of 68%-88% and negative agreement of 93%-99%. Interreader agreement was strong, with Fleiss kappa of 0.92 and 0.86. Safety data covered 1,734 subjects.
A negative scan does not exclude tau pathology, and a positive scan does not confirm it. Performance is lower in earlier disease, and safety and effectiveness are not established for non-Alzheimer tauopathies. According to the label summary from Pharmacy Times, these limits create a real risk of misdiagnosis if scans stand alone.
Does Tau Imaging Help Predict Decline
Baseline tau PET was the strongest independent predictor of Mini-Mental State Examination decline over two years. It performed best for prognosis in preclinical and prodromal mild-cognitive-impairment stages. According to the Lund University study report from Hospital Healthcare Europe, no other baseline marker predicted decline as well.
Revised Alzheimer's staging requires amyloid positivity plus the spatial extent of tau PET for stages A-D. JAMA Neurology reports a harmonized visual-read framework classified significantly more mild-cognitive-impairment cases as tau-positive than older rules. For readers, stage depends on where tau has spread, not only whether it is present.
What to Ask at Your Visit
Bring your blood-test result, symptom timeline, and medication list to the memory visit. Ask how each result changes the next choice.
These three questions help you leave with a plan. Write down whether the plan is watchful follow-up, referral for PET, or spinal-fluid testing. Bring a family member to hear the same instructions.
- Ask if my pTau217 result was validated to guide PET choice, and what cutoff was used.
- Ask what a tau PET would change: diagnosis, stage, treatment eligibility, or daily planning.
- Ask about limits: early-disease accuracy, other tau diseases, and need for repeat testing.
You Might Also Like
- Tauklarify Tau PET vs Amyloid PET After the 2026 Approval: What People With Mild Cognitive Impairment Should Know About the News
- Tauklarify Imaging for Alzheimer’s Tau Tangles in 2026: What People With Mild Cognitive Impairment Should Know About the News
- PrecivityAD2 and Younger-Onset Alzheimer’s Diagnosis in 2026: What People With Mild Cognitive Impairment Should Know About the News
